Follow
Panagiotis Tsiakanikas
Panagiotis Tsiakanikas
Verified email at biol.uoa.gr
Title
Cited by
Cited by
Year
Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer
MA Diamantopoulos, P Tsiakanikas, A Scorilas
Annals of Translational Medicine 6 (12), 2018
1162018
miR-15a-5p, a novel prognostic biomarker, predicting recurrent colorectal adenocarcinoma
CK Kontos, P Tsiakanikas, M Avgeris, IN Papadopoulos, A Scorilas
Molecular Diagnosis & Therapy 21, 453-464, 2017
452017
Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia
SG Papageorgiou, CK Kontos, P Tsiakanikas, G Stavroulaki, A Bouchla, ...
Leukemia research 70, 1-7, 2018
352018
Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology
PG Adamopoulos, CK Kontos, P Tsiakanikas, A Scorilas
Cancer letters 373 (1), 119-129, 2016
292016
High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease
P Tsiakanikas, CK Kontos, D Kerimis, IN Papadopoulos, A Scorilas
Clinical Chemistry and Laboratory Medicine (CCLM) 56 (6), 990-1000, 2018
282018
Clinical utility of microRNAs in renal cell carcinoma: current evidence and future perspectives
P Tsiakanikas, C Giaginis, CK Kontos, A Scorilas
Expert review of molecular diagnostics 18 (11), 981-991, 2018
222018
High Expression of a tRNAPro Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence
P Tsiakanikas, PG Adamopoulos, D Tsirba, PI Artemaki, IN Papadopoulos, ...
Biomedicines 10 (5), 1120, 2022
142022
A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
AM Papanota, P Tsiakanikas, CK Kontos, P Malandrakis, CI Liacos, ...
Cancers 13 (15), 3877, 2021
142021
Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies
PG Adamopoulos, P Tsiakanikas, A Scorilas
Biological chemistry 399 (8), 821-836, 2018
142018
Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach
PG Adamopoulos, P Tsiakanikas, EE Adam, A Scorilas
Genomics 113 (1), 573-581, 2021
132021
Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches
PG Adamopoulos, P Tsiakanikas, CK Kontos, A Panagiotou, ...
Gene 719, 144075, 2019
132019
Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies
MA Boti, PG Adamopoulos, P Tsiakanikas, A Scorilas
Genes 12 (6), 839, 2021
112021
A versatile 5′ RACE-Seq methodology for the accurate identification of the 5′ termini of mRNAs
PG Adamopoulos, P Tsiakanikas, I Stolidi, A Scorilas
BMC genomics 23 (1), 163, 2022
102022
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma
MA Papadimitriou, K Soureas, AM Papanota, P Tsiakanikas, ...
Journal of Translational Medicine 21 (1), 245, 2023
32023
Targeted Long-Read Sequencing Decodes the Transcriptional Atlas of the Founding RAS Gene Family Members
PG Adamopoulos, P Tsiakanikas, MA Boti, A Scorilas
International Journal of Molecular Sciences 22 (24), 13298, 2021
32021
A comprehensive nanopore sequencing methodology deciphers the complete transcriptional landscape of cyclin‐dependent kinase 4 (CDK4) in human malignancies
PG Adamopoulos, K Athanasopoulou, P Tsiakanikas, A Scorilas
The FEBS Journal 289 (3), 712-729, 2022
22022
Hybrid-seq deciphers the complex transcriptional profile of the human BRCA1 DNA repair associated gene
PG Adamopoulos, K Athanasopoulou, MA Boti, G Dimitroulis, GN Daneva, ...
RNA biology 20 (1), 281-295, 2023
2023
The interplay between miR-1245a and BRCA2 in colorectal cancer
A Scorilas, K Panoutsopoulou, P Tsiakanikas
Annals of Translational Medicine 8 (17), 2020
2020
MICRORNA-24-3P OVEREXPRESSION PREDICTS RELAPSE AND POOR OVERALL SURVIVAL OF COLORECTAL ADENOCARCINOMA PATIENTS, INDEPENDENTLY OF OTHER ESTABLISHED PROGNOSTICATORS: Cod: M224
C Kontos, P Tsiakanikas, S Christodoulou, I Papadopoulos, A Scorilas
Clinical Chemistry and Laboratory Medicine 55, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–19